For full functionality of this website it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser

Session Details

Point-of-Care Manufacturing: Does Improving Patient Access Increase their Risks?
Wednesday, May 29, 2024 09:15 AM - 10:15 AM  
Room 202-204
Regulation & Policy
Roundtable
Organized by: ISCT Early Stage Professionals Committee

Moderator
  • John Bell, PhD, FRSC, FCAHS, BioCanRx / Ottawa Hospital Research Institute/University of Ottawa, Canada
Panelists
  • Manel Juan, MD, PhD, School of Medicine, University de Barcelonas, Spain
  • Natasha Kekre, MD, MPH, FRCPC, Ottawa Hospital Research Institute, Canada
  • Rimas J. Orentas, PhD, Caring Cross Inc., United States

Improve on existing models to circumvent risks associated with decentralized manufacturing.

Key Learning Objectives

1. Better understand different jurisdictional innovative models for access to cell and gene therapies (with emphasis on CAR T cell therapy)
2. Understand regulatory hurdles across jurisdictions
3. Dispel myths regarding academically-led models, and describe how processes are undertaken to ensure safe and effective products
4. Understand the complementary nature in which different models can work together to achieve a unified goals of providing access to potentially curative therapies to our respective patient communities
 

John Bell
Senior Scientist
Ottawa Hospital Research Institute
Moderator


MANUEL JUAN OTERO
Head of Immunology Department
Hospital Clínic de Barcelona Plataforma HSJD-HCB - UB
Panelist


Natasha Kekre
Hematologist, Transplant and Cellular Therapy Program
Ottawa Hospital Research Institute
Panelist


Rimas Orentas
CSO
Caring Cross
Panelist